lovo-cel
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Genetix Biotherapeutics Inc.
Overview
lovo-cel is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
lovo-cel clinical trials
Explore related
Medical disclaimer. This page summarizes research about lovo-cel for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.